We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Cataract
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Not provided at time of registration
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
2013 Results article in http://www.ncbi.nlm.nih.gov/pubmed/24070808 results
You can take part if:
You may not be able to take part if:
1. Patients aiming for a refractive result other than bilateral emmetropia (0.00 to -0.50D spherical equivalant) or emmetropia in one eye and low myopia in the other, i.e., the intended monovision outcome2. Significant co-pathology (including macular pathology, glaucoma, uveitis, corneal disease, diabetic retinopathy, previous retinal detachment surgery)3. Keratometric astigmatism 1.5D in either eye4. Amblyopia5. Congenital or traumatic cataracts6. Poor comprehension of written or spoken English7. Inability to give informed consent8. Mobility, tremor or postural problems causing discomfort during slit lamp examination
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
This information has not yet been provided by the study team. You'll have an opportunity to discuss any risks and benefits that may be associated with this study prior to consenting to taking part.
Mr
Mark
Wilkins
+44 (0)20 7566 2036
mail@markwilkins.co.uk
The study is sponsored by Moorfields Eye Hospital NHS Foundation Trust (UK) and funded by Advanced Medical Optics (AMO) United Kingdom Ltd (UK); Bausch & Lomb UK Ltd (UK).
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
